Check out our latest article in Inside Precision Medicine. CDx Reimbursement and Funding Challenges and Potential Solutions from the European Perspective.
Our latest article in Inside Precision Medicine
Nigeria is the first country to develop Essential Diagnostics List (EDL) in Africa
Performance-based Risk-sharing Agreements in Diagnostics: Part 2, Europe
Performance-based Risk-sharing Agreements in Diagnostics: Part 1 USA
10 most exciting (digital) diagnostics news from 2019
(VIDEO) 3+1 Policy Initiatives That Will Influence Diagnostics (IVD) Access
3+1 Policy Initiatives That Will Influence Diagnostics (IVD) Access
The diagnostics industry is facing increasing policy attention. Policymakers push for broader access, better affordability and safer than ever solutions. Institutions, like the European Union (EU) and World Health Organization (WHO), are involved in introducing new regulations.
Find out what are the latest policy initiatives and how will they impact access for IVD solutions.
India drafts its own Essential Diagnostics List following WHO's
Five Diagnostics (IVD) Access Challenges & Potential Actions
WHO Essential Diagnostics List (EDL) – 3 likely impacts to the diagnostics industry
WHO Essential Diagnostics List (EDL) – 3 likely impacts to the diagnostics industry
The diagnostics industry is facing increasing policy attention. The In Vitro Diagnostic Device Regulation (IVDR) will newly regulate the European approval system, the new EU Health Technology Assessment (HTA) proposal is already on the table and World Health Organization (WHO) has just released the first Essential Diagnostics List (EDL).
Similar concept, Essential Medicines List (EML) has been around for 40 years. Looking at the history of EML what can the diagnostics industry expect?